| P-b Health Home Care | |
| 4701 Mount Hope Drive, Suite B, Baltimore, Maryland 21215 | |
| (410) 235-1060 | |
| Name | P-b Health Home Care |
|---|---|
| Location | 4701 Mount Hope Drive, Suite B, Baltimore, Maryland |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 217134 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 20723, 20755, 20794, 21012, 21029, 21030, 21032, 21037, 21042, 21043, 21044, 21045, 21046, 21054, 21060, 21061, 21075, 21076, 21090, 21093, 21108, 21113, 21117, 21120, 21122, 21128, 21133, 21136, 21144, 21146, 21162, 21163, 21201, 21202, 21203, 21204, 21205, 21206, 21207, 21208, 21209, 21210, 21211, 21212, 21213, 21214, 21215, 21216, 21217, 21218, 21219, 21220, 21221, 21222, 21223, 21224, 21225, 21226, 21227, 21228, 21229, 21230, 21231, 21234, 21236, 21237, 21239, 21244, 21286 |
| NPI Number | 1114911229 |
| Organization Name | P-B HEALTH HOME CARE AGENCY, INC. |
| Doing Business As | P-B HEALTH |
| Address | 4701 Mount Hope Dr Ste B, Baltimore, MD 21215 |
| Phone Number | 410-235-1060 |
News Archive
Fights between siblings - from toy-snatching to clandestine whacks to being banished from the bedroom - are so common they're often dismissed as simply part of growing up. Yet a new study from researchers at the University of New Hampshire finds that sibling aggression is associated with significantly worse mental health in children and adolescents.
The decision regarding a further investigation of MNsure's troubles is expected this week. A state legislative commission decides this week whether the state's new online health insurance marketplace, MNsure, should get a major, top to bottom audit. MNsure has received more than $150 million in federal grants and external reviews found poor management and serious software failures.
Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 4 days ago
| NPI Number | 1912692484 |
| Organization Name | ADORATION HOME HEALTH CARE MARYLAND, LLC |
| Address | 4701 Mount Hope Dr Ste B, Baltimore, MD 21215 |
| Phone Number | 410-235-1060 |
News Archive
Fights between siblings - from toy-snatching to clandestine whacks to being banished from the bedroom - are so common they're often dismissed as simply part of growing up. Yet a new study from researchers at the University of New Hampshire finds that sibling aggression is associated with significantly worse mental health in children and adolescents.
The decision regarding a further investigation of MNsure's troubles is expected this week. A state legislative commission decides this week whether the state's new online health insurance marketplace, MNsure, should get a major, top to bottom audit. MNsure has received more than $150 million in federal grants and external reviews found poor management and serious software failures.
Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 4 days ago
| Quality Rating: |
News Archive
Fights between siblings - from toy-snatching to clandestine whacks to being banished from the bedroom - are so common they're often dismissed as simply part of growing up. Yet a new study from researchers at the University of New Hampshire finds that sibling aggression is associated with significantly worse mental health in children and adolescents.
The decision regarding a further investigation of MNsure's troubles is expected this week. A state legislative commission decides this week whether the state's new online health insurance marketplace, MNsure, should get a major, top to bottom audit. MNsure has received more than $150 million in federal grants and external reviews found poor management and serious software failures.
Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 97.6 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.6 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 99.7 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 95.5 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 96 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.8 | 96.4 |
News Archive
Fights between siblings - from toy-snatching to clandestine whacks to being banished from the bedroom - are so common they're often dismissed as simply part of growing up. Yet a new study from researchers at the University of New Hampshire finds that sibling aggression is associated with significantly worse mental health in children and adolescents.
The decision regarding a further investigation of MNsure's troubles is expected this week. A state legislative commission decides this week whether the state's new online health insurance marketplace, MNsure, should get a major, top to bottom audit. MNsure has received more than $150 million in federal grants and external reviews found poor management and serious software failures.
Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 78.9 | 79.6 |
| How often patients got better at getting in and out of bed | 81.3 | 81.1 |
| How often patients got better at bathing | 81.3 | 82.3 |
| How often patients’ breathing improved | 95 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 92.6 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 72.9 | 75 |
| How often home health patients had to be admitted to the hospital | 14.8 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.4 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 95.7 | 94 |
News Archive
Fights between siblings - from toy-snatching to clandestine whacks to being banished from the bedroom - are so common they're often dismissed as simply part of growing up. Yet a new study from researchers at the University of New Hampshire finds that sibling aggression is associated with significantly worse mental health in children and adolescents.
The decision regarding a further investigation of MNsure's troubles is expected this week. A state legislative commission decides this week whether the state's new online health insurance marketplace, MNsure, should get a major, top to bottom audit. MNsure has received more than $150 million in federal grants and external reviews found poor management and serious software failures.
Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Fights between siblings - from toy-snatching to clandestine whacks to being banished from the bedroom - are so common they're often dismissed as simply part of growing up. Yet a new study from researchers at the University of New Hampshire finds that sibling aggression is associated with significantly worse mental health in children and adolescents.
The decision regarding a further investigation of MNsure's troubles is expected this week. A state legislative commission decides this week whether the state's new online health insurance marketplace, MNsure, should get a major, top to bottom audit. MNsure has received more than $150 million in federal grants and external reviews found poor management and serious software failures.
Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 4 days ago
The patient survey data of P-b Health Home Care is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 78 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 76 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 79 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 64 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 55 | 78 |
News Archive
Fights between siblings - from toy-snatching to clandestine whacks to being banished from the bedroom - are so common they're often dismissed as simply part of growing up. Yet a new study from researchers at the University of New Hampshire finds that sibling aggression is associated with significantly worse mental health in children and adolescents.
The decision regarding a further investigation of MNsure's troubles is expected this week. A state legislative commission decides this week whether the state's new online health insurance marketplace, MNsure, should get a major, top to bottom audit. MNsure has received more than $150 million in federal grants and external reviews found poor management and serious software failures.
Sanovas Inc., (www.sanovas.com) a life science technology company focused on developing and commercializing next generation micro-invasive diagnostics, devices and drug delivery technologies, announced today that the United States Patent and Trademark Office issued patent # 8,540,667 for the company's Multi-Balloon Catheter for Extravasated Drug Delivery.
CSL Behring announced today that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Berinert® C1-Esterase Inhibitor, Human for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE), a rare and serious genetic disorder, in adult and adolescent patients. Berinert is the first and only therapy approved for this indication in the U.S.
› Verified 4 days ago
Vna Of Maryland Location: 7008 Security Blvd, Baltimore, Maryland 21244 Ratings: Phone: (410) 594-2600 | |
Phr Of Baltimore, Inc Location: 1501 S Edgewood St Suite A, Baltimore, Maryland 21227 Ratings: Phone: (410) 368-2825 | |
Medstar Health Vna Location: 9601 Pulaski Park Drive, Suite 417, Baltimore, Maryland 21220 Ratings: Phone: (410) 933-2900 | |
The Johns Hopkins Home Health Services, Inc Location: 5901 Holabird Avenue Suite A, Baltimore, Maryland 21224 Ratings: Phone: (410) 288-8000 | |
Homecall, Inc Location: 4701 Mount Hope Drive, Suite A, Baltimore, Maryland 21215 Ratings: Phone: (410) 644-0105 | |
Johns Hopkins Pediatrics At Home Inc Location: 5901 Holabird Avenue, Suite A, Baltimore, Maryland 21224 Ratings: NA Phone: (410) 288-8000 |